Federal Register
Notices
> Manufacturers 2008 >
Roche Diagnostics Operations, Inc
FR Doc E8-17958[Federal Register: August 6, 2008 (Volume 73, Number 152)]
[Notices] [Page 45786-45787] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-99]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated February 12, 2008 and published in the Federal Register on
February 21, 2008, (73 FR 9593), Roche Diagnostics Operations, Inc., Attn:
Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, made
application by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled substances
listed in schedules I and II:
Drug
|
Schedule
|
Lysergic acid diethylamide (7315)
|
I
|
Tetrahydrocannabinols (THC) (7370)
|
I
|
Alphamethadol (9605)
|
I
|
Hydromorphone (9150)
|
II
|
Benzoylecgonine (9180)
|
II
|
Methadone (9250)
|
II
|
Morphine (9300)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances for use in diagnostic products.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Roche Diagnostics
Operations, Inc. to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Roche Diagnostics Operations, Inc. to ensure that the company's
registration is consistent with the public interest. The investigation has
included inspection
[[Page 45787]]
and testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-17958 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|